HEMA

HemaCare Corp.

 
Common Stock Alternative Reporting
Pink Limited Information
Verified Company Profile 8/22/2017
Contact Info
  • 15350 Sherman Way
  • Suite 423
  • Van Nuys, CA 91406

Business Description


 
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Apr 06, 2012
Audited Financials Audited
Latest Report Jun 30, 2017 Semi-Annual Report
CIK 0000801748
Fiscal Year End 12/31
OTC Marketplace Pink Limited
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: CA, USA
Year of Inc. 1978
Employees Not Available
Company Officers/Contacts
Pete van der Wal President, CEO
Rochelle Martel Corporate Secretary, CFO
Nestor Montano Corporate Controller
Company Directors
Steve B Gerber, MD Chairman
James G. Wolf Director, Audits, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Gil Avidar
George Scholl Compensation Committee Member
Terry Van Der Tuuk Audit Committee Member, Nominating Committee Member
Service Providers
Accounting/Auditing Firm
Rose, Snyder & Jacobs
15821 Ventura Blvd.
Suite 490
Encino, 91436
United States
 
Securities Counsel
Stubbs Alderton & Markiles, LLP OTCQX Sponsor
15260 Ventura Blvd.
20th Floor
Sherman Oaks, CA, 91403
United States
 
Investor Relations Firm

Not Available
HEMA Security Details
Share Structure
Market Value1 $33,677,001 a/o Nov 22, 2017
Authorized Shares 40,000,000 a/o Dec 31, 2016
Outstanding Shares 11,612,759 a/o Jun 30, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Computershare
Shareholders
Shareholders of Record 224 a/o Dec 31, 2016
Short Selling Data
Short Interest 4,727 (0.75%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security